A rotary imaging system, a plant imager, an animal imager, and an animal and plant imager, relating to the technical field of living sample imaging. The plant imager, the animal imager, and the animal and plant imager all comprise a rotary imaging system. The rotary imaging system comprises the sample table unit is used for carrying a sample; the camera unit is used for imaging the sample; the rotation unit comprises an accommodating cavity accommodating the sample table unit, and the rotation unit is used for driving the camera unit to rotate with respect to the sample table unit and controlling the camera unit to be stationary with respect to the sample table unit. By means of rotary imaging system, powerful data support is provided for the subsequent image reconstruction and image fusion, and the number of cameras required for imaging different parts of a sample is also reduced.

Disclosed is a method for preparing N-benzyl sulfonamides. Also disclosed is a composition for treating cancer. The composition includes a N-benzyl sulfonamide and a metabolic inhibitor. Also disclosed is a method for determining the impact on cell ATP levels of a composition containing a N-benzyl sulfonamide with or without a metabolic inhibitor.

The present application relates to methods of detecting a target nucleic acid molecule in a sample. The method includes providing a sample containing a target nucleic acid molecule and a capture oligonucleotide molecule. In one embodiment, the capture oligonucleotide molecule has (i) a length of 30-60 base pairs, (ii) a 4-8 base pair overhang on its 3′ end, (iii) a 5′ tail, (iv) a target-specific portion between the 3′ end and the 5′ tail, (v) a deoxy-adenosine diphosphate content of 40-50%, (vi) no deoxy thymidine phosphate in the 3′ end or the 5′ tail, and (vii) the 3′ end and the 5′ tail having an ATP content which is 40-50% of that of the capture oligonucleotide molecule. In another aspect of the method of detecting, certain reagents are coupled to a solid support. The present application also relates to compositions and kits useful in carrying out the methods of the present application.

The present invention relates to a detachable mixing device for a reproducible adenosine triphosphate (ATP) reaction of a commercial ATP optical measuring instrument and provides a mixing device for an ATP optical measuring instrument, the mixing device including a main body, a swab kit insertion part which is formed in the main body and provides an insertion space for an ATP reaction swab kit, a mixing module which is disposed around a lower perimeter of the swab kit insertion part and mixes a reactant in the inserted swab kit, and a coupling part disposed on one side surface of the main body and detachably attached to the ATP optical measuring instrument.

A new thermostable luciferase of the following mutant luciferase (a) or (b): (a) a mutant of a wild-type luciferase comprising the amino acid sequence of SEQ ID NO: 1, wherein phenylalanine at position 292 and/or phenylalanine at position 294 in the amino acid sequence of SEQ ID NO: 1 is substituted with another amino acid; or (b) a mutant of a luciferase having 93% or more homology with the amino acid sequence of SEQ ID NO: 1, wherein in the amino acid sequence of the mutant, the amino acid at a site corresponding to position 292 and/or position 294 in the amino acid sequence of SEQ ID NO: 1 is substituted with another amino acid.

Provided herein are enhanced luciferase enzymes for use with thermostable luciferin analogs for bioluminescent assays. In particular, the present disclosure provides compositions, assays, and methods for performing a bioluminescent assay using enhanced, high-activity luciferase enzymes compatible with thermostable luciferins, such as 5,5-disubstituted luciferin analogs.

What is provided is a fusion protein including any one of proteins of (A) to (C) below; and a tag protein that dimerizes or multimerizes in response to a stimulus, (A) a protein that consists of an amino acid sequence represented by SEQ ID NO: 1; (B) a protein that consists of an amino acid sequence having 70% or more identity with the amino acid sequence represented by SEQ ID NO: 1 and has an aggregate-forming ability, and (C) a protein that consists of an amino acid sequence obtained by performing deletion, substitution, insertion, or addition of one or several amino acids with respect to the amino acid sequence represented by SEQ ID NO: 1 and has the aggregate-forming ability.

The present invention provides a calibration device for an optical detector comprising a light emitting diode 1, and an electronic circuit 3 for driving the light emitting diode 1, wherein the electronic circuit 3 is a constant current generator configured to supply a constant driving current to the light emitting diode 1 in the range of 0.5 to 25 μA. Furthermore, the present invention provides a setting device for setting at least one calibration point for a calibration device as described above. The setting device comprises a light detector 51 configured to output a signal representing the light emission intensity of a calibration device under examination, a controller 53 for controlling the constant driving current of the calibration device under examination, and a calibration point setting means 55 for setting at least one calibration point for the calibration device under examination.

The present disclosure relates to devices, methods, and systems or kits for detecting ATP in a sample. Particularly, the present disclosure relates to methods for removing ATP contamination from a sample and detecting intracellular ATP in the sample (e.g., as a proxy for detecting live cells in the sample).

Disclosed is a method for selecting a cancer treatment regimen for a subject.